Inovalon Holdings, Inc. (INOV) EPS Estimated At $0.10

October 14, 2018 - By Dolores Ford

Inovalon Holdings, Inc. (NASDAQ:INOV) Logo

Analysts expect Inovalon Holdings, Inc. (NASDAQ:INOV) to report $0.10 EPS on November, 7.They anticipate $0.03 EPS change or 42.86 % from last quarter’s $0.07 EPS. INOV’s profit would be $15.27 million giving it 25.25 P/E if the $0.10 EPS is correct. After having $0.12 EPS previously, Inovalon Holdings, Inc.’s analysts see -16.67 % EPS growth. The stock increased 0.30% or $0.03 during the last trading session, reaching $10.1. About 437,219 shares traded. Inovalon Holdings, Inc. (NASDAQ:INOV) has declined 38.30% since October 14, 2017 and is downtrending. It has underperformed by 53.92% the S&P500.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry. The company has market cap of $1.54 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem. It currently has negative earnings. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

More news for Inovalon Holdings, Inc. (NASDAQ:INOV) were recently published by: Nasdaq.com, which released: “ABILITY Network Announces the 2018 HomeCare Elite” on October 08, 2018. Seekingalpha.com‘s article titled: “Inovalon Got It All To Show” and published on September 23, 2018 is yet another important article.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>